Skye Bioscience, Inc. Post-effective amendment to a registration statement that is not immediately effective upon filing

Warrants and Derivative Liabilities (Details 3)

Warrants and Derivative Liabilities (Details 3) - Monte Carlo simulations - Emerald Financing	Sep. 30, 2019 Percent $ / shares	Dec. 31, 2018 Percent $ / shares	Feb. 16, 2018 Percent $ / shares	Jan. 19, 2018 Percent $ / shares
Class of Warrant or Right [Line Items]
Underlying common stock price \| $ / shares	$ 0.37	$ 0.40
Minimum
Class of Warrant or Right [Line Items]
Underlying common stock price \| $ / shares			$ 0.29	$ 0.29
Maximum
Class of Warrant or Right [Line Items]
Underlying common stock price \| $ / shares			$ 0.30	$ 0.30
Dividend yield
Class of Warrant or Right [Line Items]
Warrants and rights outstanding measurement input	0.00	0.00	0.00	0.00
Volatility factor
Class of Warrant or Right [Line Items]
Warrants and rights outstanding measurement input			70.00	70.00
Volatility factor \| Minimum
Class of Warrant or Right [Line Items]
Warrants and rights outstanding measurement input	81.9	92.1
Volatility factor \| Maximum
Class of Warrant or Right [Line Items]
Warrants and rights outstanding measurement input	82.1	92.4
Risk-free interest rate
Class of Warrant or Right [Line Items]
Warrants and rights outstanding measurement input	1.56	2.49
Risk-free interest rate \| Minimum
Class of Warrant or Right [Line Items]
Warrants and rights outstanding measurement input			2.45	2.45
Risk-free interest rate \| Maximum
Class of Warrant or Right [Line Items]
Warrants and rights outstanding measurement input			2.6	2.6
Expected term (years)
Class of Warrant or Right [Line Items]
Expected Term			5 years	5 years
Expected term (years) \| Minimum
Class of Warrant or Right [Line Items]
Expected Term	3 years 3 months 22 days	4 years 18 days
Expected term (years) \| Maximum
Class of Warrant or Right [Line Items]
Expected Term	3 years 4 months 17 days	4 years 1 month 17 days